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In acute heart failure there is a positive linear 
rorrelation between left atria1 size (LA) and plasma 
eVelS of atria1 natrillrrtic peptide (ANP). In the 
ONSENSM trial in severe chronic heart failure, an 
optional protocol evalualerl rhe correlation between 
plasma ANP concentral +LHI and LA and the effect 01 
treatment with enalapril or placebo in this conlrkt. 
Yaterial anc4 method: Both M-mode echocardiography pnd 
plasma ANP concentration were available at baseline in 
71 patients. ANP levels were very elevated to 343 pg/ml 
(median). LA was 50.5 m m  (mean). 4n inverse correlaticn 
was found between ANP-concentration and LA (r= - 0.4i 
pt0.005). ANP levels were significantly decreased in the 
enalapril treated group (from 4 .rl f 485 to 323 + 345 
pg/ml pt0.01) but except for one outlier did not change 
significantly in the placebo group. LA showed no 
significant changes in either group. In the enalapril 
group after b weeks there was an increase in fractional 
shortening %  (13.3 + 5.6 to 15.k 2 5.8 $ :,<0.05) and a 
decrease in systolic t ime interval index (0.58 + Q.14 to 
0.48 +0.14 p<O.O5) were found. No significant changes in 
fractional shortening or systolic t ime interval index 
were found in the placebo group. 
Conclusion: These findings indicate that in patients 
with severe chronic congestive heart failure other 
factors than left atria1 distension are responsible for 
the plasma ANP level. 
